As PBMs Drive Up Drug Prices, Silence Is Not Golden

The Trump administration has been mum in recent weeks on its “most favored nation” drug pricing plan, which broadly aims to link U.S. prices for medicines to the lowest prices in other developed countries.

It’s unclear what those prices will be, how they’ll be determined, or how the administration will bring them about.

The administration simply promises that they’ll be lower for patients.